We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients.
- Authors
Willett, Christopher G; Boucher, Yves; Duda, Dan G; di Tomaso, Emmanuelle; Munn, Lance L; Tong, Ricky T; Kozin, Sergey V; Petit, Lucine; Jain, Rakesh K; Chung, Daniel C; Sahani, Dushyant V; Kalva, Sanjeeva P; Cohen, Kenneth S; Scadden, David T; Fischman, Alan J; Clark, Jeffrey W; Ryan, David P; Zhu, Andrew X; Blaszkowsky, Lawrence S; Shellito, Paul C; Mino-Kenudson, Mari; Lauwers, Gregory Y
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Vol 23, Issue 31, p8136
- ISSN
0732-183X
- Publication type
Research
- DOI
10.1200/JCO.2005.02.5635